We are live on ! Find out more
GMED icon

Globus Medical

79.77 USD
+0.31
0.39%
At close Updated Nov 3, 1:27 PM EST
1 day
0.39%
5 days
-0.87%
1 month
4.18%
3 months
-2.07%
6 months
-11.95%
Year to date
-8.63%
1 year
30.34%
5 years
1.97%
10 years
275.92%
 

About: Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Employees: 6,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 64.4%
Neutral 33.3%
Negative 2.2%
Positive
Seeking Alpha
1 day ago
Globus Medical: The Shrinking Robot Line Hides A Growing Annuity
Globus Medical is leveraging flexible leasing models to expand its installed base, prioritizing recurring high-margin implant sales over upfront capital revenue. GMED's post-NuVasive integration is driving structurally higher margins, with adjusted EBITDA margins rising to 35.4% and free cash flow nearly doubling year-over-year. Despite a segment revenue decline, ExcelsiusGPS placements grew 25%, supporting a transition to a more recurring, cash-generative business model.
Globus Medical: The Shrinking Robot Line Hides A Growing Annuity
Positive
Zacks Investment Research
1 day ago
GMED vs. AXGN: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and AxoGen (AXGN). But which of these two companies is the best option for those looking for undervalued stocks?
GMED vs. AXGN: Which Stock Should Value Investors Buy Now?
Positive
Zacks Investment Research
1 day ago
Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet
The consensus price target hints at a 30.5% upside potential for Globus Medical (GMED). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Think Globus Medical (GMED) Could Surge 30.52%: Read This Before Placing a Bet
Positive
Zacks Investment Research
1 day ago
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term
Positive
Zacks Investment Research
5 days ago
2 Healthcare Technology Stocks for a Digital Health Boom
GMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.
2 Healthcare Technology Stocks for a Digital Health Boom
Neutral
PRNewsWire
12 days ago
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm
Positive
Zacks Investment Research
13 days ago
Globus Medical (GMED) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Globus Medical (GMED) is a Top-Ranked Value Stock: Should You Buy?
Neutral
Zacks Investment Research
18 days ago
GMED or AXGN: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or AxoGen (AXGN). But which of these two stocks offers value investors a better bang for their buck right now?
GMED or AXGN: Which Is the Better Value Stock Right Now?
Neutral
GlobeNewsWire
20 days ago
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will highlight its latest spine innovations at the 41st Annual North American Spine Society (NASS) Meeting in San Antonio, Texas, from October 14-17.
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
Neutral
GlobeNewsWire
21 days ago
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
AUDUBON, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Thursday, November 5, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Price charts implemented using Lightweight Charts™